These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 21083281

  • 1. Interview with Janet Woodcock.
    Woodcock J.
    Bioanalysis; 2010 Sep; 2(9):1535-8. PubMed ID: 21083281
    [Abstract] [Full Text] [Related]

  • 2. Interview with Janet Woodcock: progress on the FDA's critical path initiative.
    Woodcock J.
    Biomark Med; 2009 Dec; 3(6):671-3. PubMed ID: 20477704
    [Abstract] [Full Text] [Related]

  • 3. Janet Woodcock discusses the FDA and the drug development process. Interview by Christopher Watson.
    Woodcock J.
    Drug Discov Today; 2004 Jul 01; 9(13):548-50. PubMed ID: 15203087
    [Abstract] [Full Text] [Related]

  • 4. Lessons learned from independent central review.
    Ford R, Schwartz L, Dancey J, Dodd LE, Eisenhauer EA, Gwyther S, Rubinstein L, Sargent D, Shankar L, Therasse P, Verweij J.
    Eur J Cancer; 2009 Jan 01; 45(2):268-74. PubMed ID: 19101138
    [Abstract] [Full Text] [Related]

  • 5. Complexities in drug trials: enrichment, biomarkers and surrogates. Interview with Robert Temple.
    Temple R.
    Biomark Med; 2008 Apr 01; 2(2):109-12. PubMed ID: 20477432
    [Abstract] [Full Text] [Related]

  • 6. Delegations of authority and organization; Center for Biologics Evaluation and Research, Center for Devices and Radiological Health, and Center for Drug Evaluation and Research--FDA. Final rule.
    Fed Regist; 1991 Nov 21; 56(225):58758-9. PubMed ID: 10115699
    [Abstract] [Full Text] [Related]

  • 7. Navigating the clinical trial pathway: Conception, design, execution, and results dissemination.
    Sampalis JS, Watson J, Boukas S, Boukas M, Harvey N, Machado S, Bordeleau M, Rampakakis E.
    Surgery; 2017 Mar 21; 161(3):576-583. PubMed ID: 28190508
    [Abstract] [Full Text] [Related]

  • 8. FDA reform in Congress: FDA's concerns. Food and Drug Administration.
    James JS.
    AIDS Treat News; 1996 Apr 19; (no 245):5-7. PubMed ID: 11363624
    [Abstract] [Full Text] [Related]

  • 9. Delegations of authority and organization; Center for Drug Evaluation and Research--FDA. Final rule.
    Fed Regist; 1993 Apr 01; 58(61):17093-4. PubMed ID: 10125229
    [Abstract] [Full Text] [Related]

  • 10. An interview with FDA Commissioner Frank Young. Interview by Carmella Bocchino.
    Young FE.
    Nurs Econ; 1989 Apr 01; 7(5):242-8. PubMed ID: 2812067
    [Abstract] [Full Text] [Related]

  • 11. Food and Drug Administration requirements for testing and approval of new radiopharmaceuticals.
    Harapanhalli RS.
    Semin Nucl Med; 2010 Sep 01; 40(5):364-84. PubMed ID: 20674596
    [Abstract] [Full Text] [Related]

  • 12. Food and Drug Administration approval process for ophthalmic drugs in the US.
    Lloyd R, Harris J, Wadhwa S, Chambers W.
    Curr Opin Ophthalmol; 2008 May 01; 19(3):190-4. PubMed ID: 18408492
    [Abstract] [Full Text] [Related]

  • 13. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.
    Basile EM, Tolomeo D, Gluck E.
    Food Drug Law J; 2009 May 01; 64(1):149-69. PubMed ID: 19998744
    [Abstract] [Full Text] [Related]

  • 14. Advisory committees; OTC Drugs Advisory Committee; establishment--FDA. Final rule.
    Fed Regist; 1991 Sep 24; 56(185):48103-4. PubMed ID: 10114368
    [Abstract] [Full Text] [Related]

  • 15. Memorandum of understanding between the Food and Drug Administration and the National Institutes of Health's National Institute of Dental Research--FDA. Notice.
    Fed Regist; 1998 Jun 02; 63(105):30002-5. PubMed ID: 10180274
    [Abstract] [Full Text] [Related]

  • 16. New FDA Center May Speed Approval Process.
    Cancer Discov; 2016 Sep 02; 6(9):OF5. PubMed ID: 27417310
    [Abstract] [Full Text] [Related]

  • 17. An audience with... Janet Woodcock discusses the role of the FDA in improving pharma productivity.
    Woodcock J.
    Nat Rev Drug Discov; 2004 Nov 02; 3(11):904. PubMed ID: 15558859
    [No Abstract] [Full Text] [Related]

  • 18. Development and approval of vaccines in the United States.
    Botstein P.
    Isr J Med Sci; 1986 Nov 02; 22(3-4):268-71. PubMed ID: 3528047
    [Abstract] [Full Text] [Related]

  • 19. Prescription for change: an interview with FDA Commissioner Dr. David Kessler.
    Kessler D.
    Physician Assist; 1992 Jul 02; 16(7):61-2, 65, 68-70. PubMed ID: 10120389
    [Abstract] [Full Text] [Related]

  • 20. Delegations of authority and organization; Office of the Commissioner--FDA. Final rule.
    Fed Regist; 1991 Nov 21; 56(225):58758. PubMed ID: 10115698
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.